Academic literature on the topic 'Bv630.2'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bv630.2.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Bv630.2"

1

Gatti, Arianna, Silvio Veronese, Giovanni Grillo, et al. "Multiparametric Flow Cytometry-MRD Assay: Lesson from Phase II Trail REL AML 001." Blood 142, Supplement 1 (2023): 5997. http://dx.doi.org/10.1182/blood-2023-185555.

Full text
Abstract:
Background: Core-binding factor (CBF) AML with RUNX1/RUNX1T1 (AML1/ETO) and CBFB/MYH11 fusion genes is known as a heterogenous group, accounting for about 10% to 15% of AML. In the Phase II Trial REL AML 001 (EudraCT Number 2017-002094-18; ClinicalTrials ID: NCT 03686345) adult CBF leukemia patients treated with a continuation therapy with Midostaurin were included, and the measurable residual disease (MRD) was performed by molecular MRD assessment (qPCR) and multiparametric flow cytometric-MRD (MCF-MRD) assay. The findings of MCF-MRD assay were compared to qPCR. Methods: 31 patients with AML1
APA, Harvard, Vancouver, ISO, and other styles
2

Ren, Youliang, Jason Weeks, Thomas Xue, et al. "Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S. aureus infection with osseointegration in murine models of implant-associated osteomyelitis." Bone Research 11, no. 1 (2023). http://dx.doi.org/10.1038/s41413-023-00287-4.

Full text
Abstract:
AbstractEradication of MRSA osteomyelitis requires elimination of distinct biofilms. To overcome this, we developed bisphosphonate-conjugated sitafloxacin (BCS, BV600072) and hydroxybisphosphonate-conjugate sitafloxacin (HBCS, BV63072), which achieve “target-and-release” drug delivery proximal to the bone infection and have prophylactic efficacy against MRSA static biofilm in vitro and in vivo. Here we evaluated their therapeutic efficacy in a murine 1-stage exchange femoral plate model with bioluminescent MRSA (USA300LAC::lux). Osteomyelitis was confirmed by CFU on the explants and longitudin
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Bv630.2"

1

John, Horton, Mendus Susan, and Locke John 1632-1704, eds. A Letter Concerning Toleration: In Focus. Routledge, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fullerton, Joireman Sandra, ed. Church, state, and citizen: Christian approaches to political engagement. Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Letter Concerning Toleration. Island Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Letter Concerning Toleration. NBN International, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

The small membership church: Scenarios for tomorrow. Abingdon Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!